EPIC-Norfolk Publications Database

Chemokine ligand 2 genetic variants, serum monocyte chemoattractant protein-1 levels, and the risk of coronary artery disease.

van Wijk DF, van Leuven SI, Sandhu MS, Tanck MW, Hutten BA, Wareham NJ, Kastelein JJ, Stroes ES, Khaw KT, and Boekholdt SM

Arteriosclerosis, thrombosis, and vascular biology. May 2010

(DOI : 10.1161/ATVBAHA.110.205526)

Prolactin levels and the risk of future coronary artery disease in apparently healthy men and women.

Reuwer AQ, Twickler MT, Hutten BA, Molema FW, Wareham NJ, Dallinga-Thie GM, Bogorad RL, Goffin V, Smink-Bol M, Kastelein JJ, Boekholdt SM, and Khaw KT

Circulation. Cardiovascular genetics. Dec 2009

(DOI : 10.1161/CIRCGENETICS.109.853572)

Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.

El Harchaoui K, van der Steeg WA, Stroes ES, Kuivenhoven JA, Otvos JD, Wareham NJ, Hutten BA, Kastelein JJ, Khaw KT, and Boekholdt SM

Journal of the American College of Cardiology. Aug 2006

(DOI : 10.1016/j.jacc.2006.09.043)

Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study.

Vaessen SF, Schaap FG, Kuivenhoven JA, Groen AK, Hutten BA, Boekholdt SM, Hattori H, Sandhu MS, Bingham SA, Luben R, Palmen JA, Wareham NJ, Humphries SE, Kastelein JJ, Talmud PJ, and Khaw KT

Journal of lipid research. Jun 2006

(DOI : 10.1194/jlr.M600233-JLR200)

Serum lipoprotein lipase concentration and risk for future coronary artery disease: the EPIC-Norfolk prospective population study.

Rip J, Nierman MC, Wareham NJ, Luben R, Bingham SA, Day NE, van Miert JN, Hutten BA, Kastelein JJ, Kuivenhoven JA, Khaw KT, and Boekholdt SM

Arteriosclerosis, thrombosis, and vascular biology. Dec 2005

(DOI : 10.1161/01.ATV.0000201038.47949.56)